ClinicalTrials.gg
Not yet recruitingNCT07797439NTT-SCEDUpdated Sep 25, 2026

Neuromotor Task Training in Autistic Children With Motor Difficulties

An interventional study of Neuromotor Task Training in Autism Spectrum Disorder (ASD), sponsored by Groupe Hospitalier Nord-Essonne. Not yet recruiting at 1 site in France. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Groupe Hospitalier Nord-Essonne · Not applicable, Interventional, and Treatment

Updated Sep 25, 2026Primary outcomes revisedStudy contact changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
6 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 110 studies in Autism Spectrum Disorder with a site in France — 51 open to participants now, 55 under way, 2 of them phase 3. Autism Spectrum Disorder · France.

Planned enrollment
72nd of 77
12 · median 70
Started
2026
with 14 others
No phase
58 of 110
29 open now
Primary completion
2027-06
later than 28 of 54 live
Registered
107th of 110
by date

Among the 110 studies in Autism Spectrum Disorder with a site in France, this one is the 72nd largest by planned enrollment of the 77 interventional ones that give a count, is one of 15 that started in 2026, is one of 58 with no phase, reaches primary completion later than 28 of the 54 other live ones, and was the 107th registered.

Autism Spectrum Disorder

1,726 studies on the registry are indexed under Autism Spectrum Disorder; 501 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

51 of the 110 studies in Autism Spectrum Disorder with a site in France are open now. Recruiting first, the newest first:

46 more — sign in →

All 51 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 350 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 295 (84%) stop at 75 or younger; 298 take children under 18; 92 take healthy volunteers.

This study: 6 Years to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 110 studies in Autism Spectrum Disorder with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical study is to learn whether Neuromotor Task Training (NTT) may help improve functional motor skills in autistic children who have motor difficulties.

The main question it aims to answer is:

Does Neuromotor Task Training help autistic children improve a motor skill that is difficult for them in daily life?

This study will include autistic children with motor difficulties. Each child will work on one functional motor skill chosen according to their needs and daily-life goals. Examples may include skills such as catching a ball, jumping rope, putting on a coat, or another meaningful motor task.

Participants will take part in an initial assessment of their motor abilities. They will then choose, with their family and the researcher, a functional motor skill to work on. The selected skill will be assessed repeatedly before, during, and after the training period. Participants will receive Neuromotor Task Training sessions focused on this skill. They will also be followed after the training period to see whether the motor skill is maintained.

Neuromotor Task Training is a task-oriented rehabilitation approach. It focuses on practicing meaningful motor skills in conditions that are progressively adapted to the child. The task, the environment, and the feedback provided by the therapist may be adjusted during the sessions to support motor learning.

This study uses a single-case experimental design. This means that each participant's progress is measured repeatedly over time. The researchers will examine whether motor performance changes after the start of the training and whether these changes are maintained after the training period.

Read the detailed description

Autism spectrum disorder is frequently associated with motor difficulties that may affect autonomy, participation in daily activities, and quality of life. These difficulties may involve balance, coordination, motor planning, object manipulation, fine motor skills, gross motor skills, or the learning of functional motor skills. This study evaluates the use of Neuromotor Task Training (NTT), a task-oriented rehabilitation approach, in autistic children with motor difficulties.

The study will include 12 autistic children aged 6 to 10 years who present motor difficulties. Participants will be recruited in the context of their usual clinical care pathway, including child and adolescent mental health or medico-psychological services. Inclusion will require a diagnosis of autism spectrum disorder, an intelligence quotient of 70 or above, and motor difficulties documented through clinical assessment and standardized motor assessment. Standardized assessments may include the Movement Assessment Battery for Children, Third Edition (MABC-3), and the Developmental Coordination Disorder Questionnaire (DCD-Q), in order to document the presence and severity of motor difficulties in daily life.

The study uses a concurrent multiple-baseline single-case experimental design replicated across three successive cohorts of four participants. This design is well suited to the evaluation of individualized rehabilitation approaches in small clinical samples. Each participant serves as their own control through repeated measurements across successive study phases. Within each cohort, the introduction of the intervention will be staggered across participants to provide multiple opportunities to demonstrate an intervention effect at different points in time. Replication of the experimental procedure across three independent cohorts is intended to strengthen the internal validity of the study.

The study procedure includes four main stages: inclusion and initial assessment, pre-intervention baseline, intervention, and post-intervention follow-up.

During the inclusion and initial assessment stage, eligibility criteria will be checked. Motor difficulties will be documented using standardized motor tools and clinical assessment. The child's ability to understand and participate in the motor training sessions will also be considered. Written informed consent will be obtained from the child's legal representative(s), and the child's assent will be sought whenever possible according to age and level of understanding.

The pre-intervention baseline phase will last approximately 6 to 9 weeks. During this phase, the child, family, and researcher or therapist will identify one meaningful functional motor skill that is difficult for the child in daily life. Examples may include catching a ball, jumping rope, putting on a coat, cutting with scissors, or another functional task relevant to the child's autonomy and participation. The selected target skill will be defined in measurable terms so that repeated performance assessments can be conducted throughout the study.

During the baseline phase, the primary outcome will be assessed once weekly. In accordance with the What Works Clearinghouse single-case design standards (Version 5.0), each participant will complete a minimum of six baseline assessments. Within each cohort, introduction of the intervention will be staggered across participants, resulting in baseline phases of approximately 6, 7, 8, and 9 weeks, respectively. Baseline measurements will continue for participants who have not yet entered the intervention phase. Individualized goals will also be formalized using Goal Attainment Scaling (GAS), and a sensory profile assessment will be administered to identify sensory preferences, sensitivities, or aversions that may influence the child's engagement, learning conditions, response to feedback, or tolerance of the practice environment.

The intervention phase will consist of 10 Neuromotor Task Training sessions. NTT is a task-oriented rehabilitation approach based on the direct practice of meaningful motor tasks. The intervention focuses on a functional motor skill selected according to the child's needs, family priorities, and clinical assessment. The therapist analyzes the task requirements, including spatial, temporal, sequential, coordinative, and environmental demands. The therapist also analyzes the child's performance in order to identify factors that may limit successful task execution.

During the NTT sessions, task constraints, environmental conditions, and individual support will be adjusted progressively. These adaptations may include changes in distance, speed, object size, spatial organization, task complexity, attentional demands, or environmental constraints. Instructions, demonstrations, practice structure, and feedback will be adapted according to the child's stage of motor learning and sensory profile. Feedback may focus on the result of the action, the quality of movement, or environmental cues that help the child adjust their performance. The aim is to support the emergence, stabilization, and generalization of more efficient motor coordination.

Repeated motor performance measurements will be collected during each intervention session. The performance metric will be selected according to the target skill and will be objective, functional, and sensitive to change. Examples may include the number of successful trials, time needed to complete the task, accuracy, or another task-specific quantitative indicator. These repeated measurements will make it possible to describe each participant's learning trajectory over time.

To limit assessment bias, motor performance measures may be video-recorded and rated secondarily by an external outcome assessor who is not involved in the training sessions. When feasible, the assessor will be masked to the study phase. This procedure is intended to improve the reliability of outcome assessment while taking into account the practical constraints of a rehabilitation study conducted in a clinical setting.

After the 10-session intervention phase, a post-intervention follow-up phase will be conducted for approximately 3 to 5 weeks. During this phase, repeated performance measurements will continue without active NTT training on the target skill. This phase will allow the researchers to examine whether the acquired motor performance is maintained after the intervention. The follow-up phase will also help document retention and possible generalization of the motor skill to daily-life contexts, such as home, school, or other relevant environments.

Goal Attainment Scaling will be rated after completion of the 10-session intervention and again at the end of the 5-week follow-up phase to quantify the extent to which the individualized functional goal has been achieved and maintained. The MABC-3 will be used at baseline to characterize participants' motor difficulties and will not constitute a pre-specified intervention outcome.

The primary focus of the study is the change in performance on the individualized functional motor skill across baseline, intervention, and follow-up phases. Visual analysis of repeated performance data will be used to examine level, trend, slope, stability, immediacy of effect, overlap between phases, and maintenance of gains. Statistical analyses adapted to single-case experimental designs may also be used, including non-overlap indices such as Tau-U or modified Tau-U, in order to quantify the magnitude of change between phases.

Secondary and exploratory analyses may examine individual learning profiles, variability of response to NTT, maintenance of gains, and the possible contribution of sensory profile characteristics to intervention adaptation. When appropriate, exploratory analyses may also use dimensional reduction or clustering approaches to describe patterns of response across participants. These analyses will remain exploratory and will be interpreted with caution because of the small sample size and individualized nature of the intervention.

This study is designed to provide clinically relevant information about the implementation of task-oriented motor rehabilitation in autistic children with motor difficulties. It aims to document whether NTT may help improve meaningful functional motor skills, how performance changes over time, and under which clinical conditions this approach may be adapted to the needs of autistic children.

03

Conditions studied

  • Autism Spectrum Disorder (ASD)

Keywords

  • Developmental Coordination Disorder
  • Motor Skills
  • Motor Difficulties
  • Motor Learning
  • Motor Rehabilitation
  • Neuromotor Task Training
  • Single-Case Experimental Design
  • Task-Oriented Training
04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 6 to 10 years.

    • Diagnosis of autism spectrum disorder.
    • Presence of motor difficulties documented by clinical assessment and/or standardized motor assessment.
    • Ability to understand and participate in the proposed motor training sessions.
    • Written from the child's legal representative(s).
    • Child assent whenever possible, according to age and level of understanding.
    • Participation in the usual care pathway at the investigating center.

Exclusion criteria

Exclusion Criteria:

  • Intelligence quotient below 70, when documented, or severe cognitive impairment preventing understanding of the tasks or participation in the training sessions.
  • Medical, neurological, orthopedic, or sensory condition that would contraindicate participation in motor training.
  • Uncontrolled epilepsy or any unstable medical condition that could interfere with participation.
  • Severe behavioral difficulties making repeated assessment or motor training impossible.
  • Ongoing participation in another interventional study that could interfere with the outcomes of this study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Neuromotor Task Training

    Participants will be enrolled in three successive cohorts of four children. All participants will receive Neuromotor Task Training focused on an individualized functional motor skill. The cohort structure is used to support replication within the single-case experimental design. It does not correspond to different intervention groups.

    Behavioral: Neuromotor Task Training

Interventions

  • BehavioralNeuromotor Task Training

    Neuromotor Task Training is a task-oriented rehabilitation approach focused on the practice of meaningful functional motor skills. The therapist analyzes the selected task and adapts task constraints, environmental conditions, practice organization, and feedback to support motor learning. In this study, each participant will receive Neuromotor Task Training sessions targeting an individualized motor skill selected before the intervention phase.

06

What researchers measure

Primary outcomes

  1. Performance on the Individualized Functional Motor Skill

    Motor performance will be assessed using one predefined, task-specific, directly observable quantitative indicator for each individualized functional motor skill. Depending on the selected skill, the indicator may be the number or proportion of successful trials, completion time, accuracy, or another objective task-specific measure. The indicator and the direction indicating improvement will be defined before baseline and will remain unchanged throughout baseline, intervention, and follow-up. Each skill and participant will be analyzed separately in the original unit of measurement; data from different task-specific indicators will not be aggregated.

    Time frame: Once weekly during the 6- to 9-week baseline phase, at each of the 10 intervention sessions, and once weekly during the 5-week post-intervention follow-up phase.

Secondary outcomes

  1. Goal Attainment Scaling Attainment Level

    Attainment of the individualized functional motor goal will be assessed using Goal Attainment Scaling (GAS). Goal achievement is rated on a five-point ordinal scale ranging from -2 to +2, where -2 indicates a level much lower than the expected outcome, -1 a level lower than expected, 0 the expected level of attainment, +1 a level higher than expected, and +2 a level much higher than expected. Higher scores indicate greater goal attainment.

    Time frame: At baseline goal setting, after completion of the 10-session intervention, and at the end of the 5-week follow-up phase.

07

Study locations

1 site
  • Groupe Hospitalier Nord-Essonne
    Bures-sur-Yvette, Essone 91440, France
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study includes a small sample of children and may involve sensitive clinical and video-recorded data. Sharing individual-level data could increase the risk of participant identification. Aggregated and anonymized results may be shared in scientific publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

Of 801 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 8 months is below that.

Counting every sponsor, half of 824 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2026
First posted
Sep 1, 2026
StartEst.
Oct 2026
Primary completionEst.
Jun 2027
CompletionEst.
Dec 2027
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Groupe Hospitalier Nord-Essonne · Bures-sur-Yvette, France
Show 1 removed
  • Groupe Hospitalier Nord-Essonne · Bures-sur-Yvette, France
Sep 25, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in Performance on the Individualized Functional Motor SkillTime frame: Weekly throughout baseline (5 to 8 assessments), the 10-week intervention period, and the 5-week follow-up period. → Once weekly during the 6- to 9-week baseline phase, at each of the 10 intervention sessions, and once weekly during the 5-week post-intervention follow-up phase.
Sep 25, 2026
Secondary outcomes
1 added
What changed in the outcomes
  • AddedGoal Attainment Scaling Attainment LevelTime frame: At baseline goal setting, after completion of the 10-session intervention, and at the end of the 5-week follow-up phase.
Sep 25, 2026
Contact
Study contact changed: a•••@polesante.eu · •••6643→a•••@polesante.eu · •••6643. See the current contact
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    1 site added, 1 site removed
    Show site
    • Groupe Hospitalier Nord-Essonne · Bures-sur-Yvette, France
    Show 1 removed
    • Groupe Hospitalier Nord-Essonne · Bures-sur-Yvette, France
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in Performance on the Individualized Functional Motor SkillTime frame: Weekly throughout baseline (5 to 8 assessments), the 10-week intervention period, and the 5-week follow-up period. → Once weekly during the 6- to 9-week baseline phase, at each of the 10 intervention sessions, and once weekly during the 5-week post-intervention follow-up phase.
    Secondary outcomes 1 added
    What changed in the outcomes
    • AddedGoal Attainment Scaling Attainment LevelTime frame: At baseline goal setting, after completion of the 10-session intervention, and at the end of the 5-week follow-up phase.
    Contact Study contact changed: a•••@polesante.eu · •••6643→a•••@polesante.eu · •••6643. See the current contact
    + 3 other changes: verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07797439
Lead sponsor
Groupe Hospitalier Nord-Essonne
Responsible party
Sponsor
First posted
Sep 1, 2026
Start date
Oct 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Sep 25, 2026

Study contacts

Aurélien D'Ignazio, MSc (PhD studend)
Contact
aurelien.d-ignazio@polesante.eu
+33 6 89 56 66 43
Aurélien D'Ignazio, MSc
principal investigator · Groupe Hospitalier Nord-Essonne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion